Defining the Molecular Landscape of Cancer-Associated Stroma in Cutaneous Squamous Cell Carcinoma.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
12 2022
Historique:
received: 28 06 2021
revised: 01 06 2022
accepted: 10 06 2022
pubmed: 20 7 2022
medline: 24 11 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide. Cancer-associated stroma (CAS) is central to tumor development and strongly influences therapy response. Perineural infiltration (PNI) represents a major risk factor for cSCC and likely influences CAS reprogramming. However, stromal reprogramming in cSCC remains poorly characterized, and it is unknown whether and how PNI influences CAS. To address these questions, we analyzed CAS and matched normal stroma from 20 cSCC cases (11 without PNI and 9 with PNI) by laser-capture microdissection using RNA sequencing. Our analysis reveals extensive stromal reprogramming strongly driven by changes in immune cells, as validated using immunohistochemistry. Furthermore, CAS of cSCC displays markers of immune exhaustion, and multiplex spatial analysis suggests that PD-L1 expression on NK T cells contributes to T-cell exhaustion and immunosuppression. Finally, PNI is characterized by increased IL-17A. In PNI-negative cases, IL-17A derives predominantly from CD3+ cells. However, with PNI, we observe an increased contribution of fibroblasts to high IL-17A, which coincides with a significant increase in FAP+ cells. Our analysis elucidates the molecular landscape of CAS in cSCC and identifies the presence of immunosuppressive mechanisms, supporting further research into immunotherapy and anti‒IL-17A in cSCC, especially for cases with PNI.

Identifiants

pubmed: 35850206
pii: S0022-202X(22)01669-4
doi: 10.1016/j.jid.2022.06.017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3304-3312.e5

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Erin Beebe (E)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.

Zahra Motamed (Z)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.

Lennart Opitz (L)

Functional Genomics Center Zürich, University of Zürich/ETH Zürich, Zürich, Switzerland.

Phil F Cheng (PF)

Department of Dermatology, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.

Mitchell P Levesque (MP)

Department of Dermatology, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.

Enni Markkanen (E)

Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zurich, Switzerland.

Laurence Feldmeyer (L)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: laurence.feldmeyer@insel.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH